Regulation of PD-L1 in cutaneous lymphoma by miRNAs
4 Views
administrator
08/09/23
Improving our understanding of how immune checkpoints are regulated in cutaneous T-cell lymphoma (CTCL) is essential to advancing our treatment of the disease using agents targeting these pathways. Here, Christiane Querfeld, MD, PhD, from City of Hope, Duarte, CA, discusses her group's work on the regulation of PD-L1 expression by miRNAs in CTCL. This interview was recorded at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland.
-
Category
Show more
Facebook Comments
No comments found